Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Change in Intangibles (2018 - 2025)

Historic Change in Intangibles for ImmunoTech (AIM) over the last 11 years, with Q2 2025 value amounting to $227000.0.

  • ImmunoTech's Change in Intangibles fell 87.34% to $227000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $402000.0, marking a year-over-year decrease of 3588.52%. This contributed to the annual value of $538000.0 for FY2024, which is 803.42% down from last year.
  • Per ImmunoTech's latest filing, its Change in Intangibles stood at $227000.0 for Q2 2025, which was down 87.34% from $56000.0 recorded in Q1 2025.
  • In the past 5 years, ImmunoTech's Change in Intangibles ranged from a high of $229000.0 in Q2 2024 and a low of $50000.0 during Q1 2024
  • For the 3-year period, ImmunoTech's Change in Intangibles averaged around $144333.3, with its median value being $140000.0 (2024).
  • Within the past 5 years, the most significant YoY rise in ImmunoTech's Change in Intangibles was 13854.17% (2024), while the steepest drop was 4278.85% (2024).
  • Over the past 3 years, ImmunoTech's Change in Intangibles (Quarter) stood at $208000.0 in 2023, then plummeted by 42.79% to $119000.0 in 2024, then soared by 90.76% to $227000.0 in 2025.
  • Its Change in Intangibles was $227000.0 in Q2 2025, compared to $56000.0 in Q1 2025 and $119000.0 in Q4 2024.